Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Mol Genet Metab. 2021 Jan 14;132(2):146–153. doi: 10.1016/j.ymgme.2021.01.005

Table 1.

Patient lab values at initial presentation (I), peak of illness (P), and most recent (R). Age at initial, peak, and most recent lab values provided in parentheses.

Phase Bicarbonate Lactate Ammonia CK AST ALT PT/INR PTT Conjugated bilirubin
Ref. range 18–29 mmol/L 0.5–1.6 mmol/L 9–33 umol/L 60–305 U/L 20–64 U/L Patients 1–4
35–140 U/L Patients 5–6
12–42 U/L Patients 1–4 6–50 U/L Patients 5–6 10.9–13.4s / 0.8–1.2 22–36s 0–0.3 mg/dL
Patient 1 I (3m) 11 12.7 11 60 151 87 16/1.32 34.7 0.2
P (3m) 18.5 38 1383 (15m) 376 165 21.4/1.86 46.6 0.1
R (41m) 3.0 <9 682 98 40 12.6/1.04 27.9 0.6
Patient 2 I (2m) 24 2.5 33 91 (1m) 48 (1m) 15.8/1.2 38 1.5 (1m)
P (6m) 9.7 83 142 (10m) 1322 918 16.2/1.6 38 (2m) 1.5 (1m)
R (10m) 4.8 14 142 161 121 14.3/1.2 33.3 0.8 (10m)
Patient 3 I (2m) 3.6 10.7 <9 711 190 324 19.3/1.79 60.6 1.3
P (3m) 19.3 (9w) 393 4099 2615 503 43/4.26 192.4 20.9
R (3y) 1.4 (19m) 17 (13m) 67 67 12.6/1.1 33 0
Patient 4 I (2w) 22 (3w) 10.8 51 79 64 16.5/1.3 (3w) 40.6 (3w) <0.1
P (3m) 24.8 393 158 (2m) 367 65 (5d) 38.4/3.77 199.2 0.7
R (N/A)
Patient 5 I (<1w) 7 14.8 165 221 89 24 15.1 / 1.2 (1m) 32.0 (1m) 0.0
P (2m) >19.9 344 (<1w) 1228 309 62.1 / 7.2 53.5 8.3
R (N/A)
Patient 6 I (<1w) 16 5.7 17 64 24 15.7 / 1.2 35.7 0.0
P (3m) 41.9 90 (2m) 73 (2m) 540 347 19.7 / 1.6 34.8 (2m) 8.5
R (15m) 5.5 117 72 15.4 / 1.2 0.0

m: months, w: weeks. Reference ranges for PT/INR and PTT are approximate, as normal reference values vary in infancy.